Syncytia Formation in Oncolytic Virotherapy
Oncolytic virotherapy uses replication-competent virus as a means of treating cancer. Whereas this field has shown great promise as a viable treatment method, the limited spread of these viruses throughout the tumor microenvironment remains a major challenge. To overcome this issue, researchers have...
Main Authors: | Chase Burton, Eric Bartee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770519300907 |
Similar Items
-
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
by: Burton C, et al.
Published: (2019-12-01) -
Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01) -
Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01) -
Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy
by: Erica B. Flores, et al.
Published: (2020-12-01) -
Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)